-
News & ResourcesNews & Resources
-
Our PipelineOUR PIPELINE
A series of biosimilar drugs are currently under advanced clinical and nonclinical development stages. Based on the technology and capabilities established from the successful development of these biosimilars, the next tier of biosimilars and new antibody therapeutics are under development.
-
Our TechnologyOUR TECHNOLOGY
Prestige Biopharma facilitates pharmaceutical R&D activities through well-equipped multidisciplinary infrastructure ranging from discovery through nonclinical and clinical development.
LATEST HAPPENINGS
Korea R&D Centre (Busan)
MOU with Busan City
Korea Vaccine Centre (Osong)
MOU with Cytiva
